Position in PFE
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$154,810
-$25,716 QoQ
Shares Held
6,429
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#2,491
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 65%
Shared 0%
None 35%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Hartford Financial Management Inc. holds $6,345,354 across 10 Drug Manufacturers - General names. PFE ranks #5 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
9,405 | $2,388,587 | |
| 2 | MRK |
Merck & Co., Inc.
|
15,754 | $2,024,389 | |
| 3 | LLY |
ELI LILLY & Co
|
894 | $1,072,290 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
10,183 | $586,744 | |
| 5 | PFE |
Pfizer Inc
This page
|
6,429 | $154,810 | |
| 6 | ABBV |
AbbVie Inc.
|
191 | $48,063 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
289 | $36,512 | |
| 8 | AMGN |
Amgen Inc
|
80 | $28,969 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $154,810 | 6,429 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $180,526 | 6,429 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $160,082 | 6,429 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $163,810 | 6,429 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $158,262 | 6,529 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $165,444 | 6,529 | Shares | Sole | 2025-04-21 | |
| 2024-12-31 | $173,214 | 6,529 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $173,640 | 6,000 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $167,880 | 6,000 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $142,218 | 5,125 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $89,968 | 3,125 | Shares | Sole | 2024-01-29 | |
| 2023-09-30 | $158,453 | 4,777 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $175,220 | 4,777 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $106,569 | 2,612 | Shares | Sole | 2023-04-25 | |
| 2022-12-31 | $2,602,428 | 50,789 | Shares | Sole | 2023-02-01 | |
| 2022-09-30 | $2,244,406 | 51,289 | Shares | Sole | 2022-10-25 | |
| 2022-06-30 | $2,684,101 | 51,194 | Shares | Sole | 2022-07-21 | |
| 2022-03-31 | $2,650,313 | 51,194 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $3,023,005 | 51,194 | Shares | Sole | 2022-01-27 | |
| 2021-09-30 | $2,214,154 | 51,480 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $2,010,239 | 51,334 | Shares | Sole | 2021-07-27 | |
| 2021-03-31 | $1,859,830 | 51,334 | Shares | Sole | 2021-04-14 | |
| 2020-12-31 | $1,883,825 | 51,177 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $1,878,194 | 51,177 | Shares | Sole | 2020-10-16 | |
| 2020-06-30 | $1,673,489 | 51,177 | Shares | Sole | 2020-07-23 | |
| 2020-03-31 | $1,673,679 | 51,277 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||